Carl Dieffenbach Ph.D
Director, DAIDS, NIAID
National Institutes of Health, Bethesda, MD
Title: Drug Development for HIV: We have come so far, and we are not yet done
Carl W. Dieffenbach, Ph.D., serves as Director of the Division of AIDS (DAIDS). Dr. Dieffenbach oversees a global HIV/AIDS research portfolio of more than $1 billion and a staff of more than 150 federal employees. He played a key role in restructuring the DAIDS-supported clinical trials research networks and has actively fostered collaboration and partnerships with other federal agencies, international research organizations, foundations, and industry. In 1992, he joined DAIDS as the chief of the preclinical therapeutics group. Upon his appointment, Dr. Dieffenbach spearheaded important research initiatives that accelerated the progress of basic research on HIV pathogenesis and directly resulted in new clinical studies of novel AIDS therapies. In 1996, he was promoted to Director of the DAIDS Basic Sciences Program, where he remained until being selected as the division director in 2008. In 2011, Dr. Dieffenbach received the Distinguished Alumnus Award of the Department of Chemistry and Biochemistry, University of Maryland.
United Scientific Group (USG) a non-profit Scientific Organization cordially invites all the participants from all over the world to attend "5 th International Conference on Drug Discovery, Development and Lead Optimization" during Nov 21-23, 2019 | Boston, MA (Drug Discovery-2019).
United Scientific Group (USG) a non-profit Scientific Organization successfully completed the First International Conference on Clinical Sciences and Drug Discovery in Baltimore, MD, USA during November 2-4, 2015 (CSDD-2015), Second Edition in Dundee, Scotland, UK during July 27-29 2016 (CSDD-2016), Third Edition in Reston, VA, USA during November 9-11, 2017 (CSDD-2017)... Read More
The conference covers hottest therapeutic areas and the latest drug development models in the pharm and Biotech industry. The subject areas may include, but are not limited to the following domains:
United Scientific Group (USG) a non-profit Scientific Organization, an expert-driven initiative led by the editor’s association and the advisory board which includes academicians, researchers, and industry leaders across various fields of research. USG provides broad range of services in the fields of science and technology including publishing, conducting world class scientific events, and holding highly interactive and proficient world forums. For more information, please visit:
Drug Discovery-2019 will be an invaluable resource for researchers, clinicians, healthcare professionals across different therapeutic and research areas.
Thanks to organising committee for such an excellent event.
Government Medical College, Nagpur, India
I enjoyed being part of it. I got to know two persons. A possible suggestion for future editions is the publishing of proceedings with SCOPUS index.
Universidad de las Américas, Mexico
It was a really nice conference with innovative presentations . I really learnt alot and the sessions were really interesting. Thank you giving me this opportunity to present my study in a very academic and friendly environment.
SKM Cancer Hospital & Research Centre, Pakistan
Be the first to receive exclusive discounts and the latest news on our conference directly in your inbox.